Breath Test Technology Shows Promise for Early Lung Cancer Detection
University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.
Read MorePosted by CLP Edit Staff | Nov 7, 2025 | Lung Cancer |
University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.
Read MorePosted by CLP Edit Staff | Oct 31, 2025 | Cancer |
A new study demonstrates the capability of a blood test in detecting ovarian cancer up to three years prior to diagnosis in prospectively collected samples.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Breast |
The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Cancer |
PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Lung Cancer |
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.
Read More